4.7 Article

Sox2 Expression Marks Castration-Resistant Progenitor Cells in the Adult Murine Prostate

Journal

STEM CELLS
Volume 37, Issue 5, Pages 690-700

Publisher

OXFORD UNIV PRESS
DOI: 10.1002/stem.2987

Keywords

Sox2; Prostate; Stem cell; Regeneration

Funding

  1. University of Chicago Section of Urology
  2. Ben May Institute for Cancer Research
  3. University of Chicago Comprehensive Cancer Center (UCCCC)
  4. University of Chicago Comprehensive Cancer Center (UCCCC), Cancer Center Support Grant [P30CA014599]
  5. Alvin Baum Family Fund
  6. Pierce Family Foundation
  7. UChicago Molecular and Cellular Biology Training Grant [NIH NIGMS T32GM007183]
  8. Cancer Biology Training Grant [T32 CA 009594]
  9. [R01CA178431]
  10. [NIH NIDDK DK111131]
  11. [CA232651]

Ask authors/readers for more resources

Identification of defined epithelial cell populations with progenitor properties is critical for understanding prostatic development and disease. Here, we demonstrate that Sox2 expression is enriched in the epithelial cells of the proximal prostate adjacent to the urethra. We use lineage tracing of Sox2-positive cells during prostatic development, homeostasis, and regeneration to show that the Sox2 lineage is capable of self-renewal and contributes to prostatic regeneration. Persisting lumina! cells express Sox2 after castration, highlighting a potential role for Sox2 in cell survival and castration-resistance. In addition to revealing a novel progenitor population in the prostate, these data implicate Sox2 as a regulatory factor of adult prostate epithelial stem cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytola, Harri M. Itkonen, Ilsa M. Coleman, Daniel Vodak, Liisa Sjoblom, Xia Sheng, Teemu Tolonen, Sarah Minner, Christoph Burdelski, Kati K. Kivinummi, Annika Kohvakka, Steven Kregel, Mandeep Takhar, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Paul Lloyd, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Donald J. Vander Griend, Stefan Knapp, Eva Corey, Felix Y. Feng, Peter S. Nelson, Fahri Saatcioglu, Karen E. Knudsen, Teuvo L. J. Tammela, Guido Sauter, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, Ian G. Mills

CELL REPORTS (2017)

Article Biochemistry & Molecular Biology

Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells

Taylor C. Peak, Prakash R. Praharaj, Gati K. Panigrahi, Michael Doyle, Yixin Su, Isabel R. Schlaepfer, Ravi Singh, Donald J. Vander Griend, Julie Alickson, Ashok Hemal, Anthony Atala, Gagan Deep

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Oncology

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Wassim Abida, Gerald L. Andriole, Chris H. Bangma, Justin E. Bekelman, Mitchell C. Benson, Amie Blanco, Arthur Burnett, William J. Catalona, Kathleen A. Cooney, Matthew Cooperberg, David E. Crawford, Robert B. Den, Adam P. Dicker, Scott Eggener, Neil Fleshner, Matthew L. Freedman, Freddie C. Hamdy, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, William B. Isaacs, Christopher J. Kane, Philip Kantoff, R. Jeffrey Karnes, Lawrence I. Karsh, Eric A. Klein, Daniel W. Lin, Kevin R. Loughlin, Grace Lu-Yao, S. Bruce Malkowicz, Mark J. Mann, James R. Mark, Peter A. Mccue, Martin M. Miner, Todd Morgan, Judd W. Moul, Ronald E. Myers, Sarah M. Nielsen, Elias Obeid, Christian P. Pavlovich, Stephen C. Peiper, David F. Penson, Daniel Petrylak, Curtis A. Pettaway, Robert Pilarski, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Mark E. Robson, Matt T. Rosenberg, Howard Sandler, Oliver Sartor, Edward Schaeffer, Gordon F. Schwartz, Mark S. Shahin, Neal D. Shore, Brian Shuch, Howard R. Soule, Scott A. Tomlins, Edouard J. Trabulsi, Robert Uzzo, Donald J. Vander Griend, Patrick C. Walsh, Carol J. Weil, Richard Wender, Leonard G. Gomella

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib

Eman L. Dadashian, Erin M. McAuley, Delong Liu, Arthur L. Shaffer, Ryan M. Young, Jessica R. Iyer, Michael J. Kruhlak, Louis M. Staudt, Adrian Wiestner, Sarah E. M. Herman

CANCER RESEARCH (2019)

Article Oncology

PEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer

Mariya Shapovalova, John K. Lee, Yingming Li, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Scott M. Dehm, Aaron M. LeBeau

CANCER RESEARCH (2019)

Article Oncology

Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography

Hallie M. Hintz, Joseph P. Gallant, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Aaron M. LeBeau

CLINICAL CANCER RESEARCH (2020)

Article Biology

MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans

Calvin VanOpstall, Srikanth Perike, Hannah Brechka, Marc Gillard, Sophia Lamperis, Baizhen Zhu, Ryan Brown, Raj Bhanvadia, Donald J. Vander Griend

ELIFE (2020)

Article Biochemistry & Molecular Biology

SOX2 mediates metabolic reprogramming of prostate cancer cells

Larischa de Wet, Anthony Williams, Marc Gillard, Steven Kregel, Sophia Lamperis, Lisa C. Gutgesell, Jordan E. Vellky, Ryan Brown, Kelly Conger, Gladell P. Paner, Heng Wang, Elizabeth E. Platz, Angelo M. De Marzo, Ping Mu, Jonathan L. Coloff, Russell Z. Szmulewitz, Donald J. Vander Griend

Summary: This study investigated the impact of SOX2 expression on patient outcomes and its function within prostate cancer cells. The results revealed that SOX2 expression promotes metastatic progression and therapy resistance in prostate cancer, and affects the metabolic pathways and metabolites of cancer cells. These findings contribute to a better understanding of the role of SOX2 in prostate cancer and suggest its potential as a biomarker and pharmacologic target in clinical settings.

ONCOGENE (2022)

Article Public, Environmental & Occupational Health

SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load

Martin Skarzynski, Erin M. McAuley, Ezekiel J. Maier, Anthony C. Fries, Jameson D. Voss, Richard R. Chapleau

Summary: The study evaluates the real-world capabilities of a genome-based clinical severity predictive algorithm using PCR as a surrogate for viral load. The results suggest that the severity predicted by a genome-based algorithm is related to clinical diagnostic tests and relative severity can be inferred from diagnostic values.

GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS (2022)

Article Oncology

Single-cell RNA sequencing of human prostate basal epithelial cells reveals zone-specific cellular populations and gene expression signatures

Jordan E. Vellky, Yaqi Wu, Daniel Moline, Jenny Drnevich, Mark Maienschein-Cline, Klara Valyi-Nagy, Andre Kajdacsy-Balla, Donald J. Vander Griend

Summary: This study reveals the gene expression differences in human prostate basal cell populations through single-cell RNA sequencing, providing insights into the potential roles of basal cells in prostatic diseases.

JOURNAL OF PATHOLOGY (2023)

Review Biochemistry & Molecular Biology

HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions

Hannah Brechka, Raj R. Bhanvadia, Calvin VanOpstall, Donald J. Vander Griend

GENES & DISEASES (2017)

No Data Available